Multiple Symmetric Lipomatosis: A Cross-Sectional Study to Investigate Clinical Features and Patients' Quality of Life

Within the subcutaneous adipose tissue diseases, multiple symmetric lipomatosis (MSL) (syn.: Launois Bensaude Syndrome, Morbus Madelung, benign symmetric lipomatosis) is rare. The pathogenesis of MSL remains unclear. We investigated the largest German cohort of MSL patients to obtain anamnestic data and quality of life with a standard questionnaire. Twenty-nine patients with confirmed MSL were included and filled in a questionnaire designed for this study. The questionnaire assessed common anamnestic factors, such as quality of life (EQ-5D-3L) and subjective treatment goals and success (“Patient-Benefit-Index-Lymphedema”, PBI-L). The gender distribution of the patients involved in the study was m/f: 1/4 (male: n = 6 (21%); female n = 23 (79%)). While the exact pathophysiology of MSL remains unclear, a subset of patients’ positive family history suggests a strong genetic factor, sometimes compatible with autosomal dominant inheritance. Patients with MSL showed lower health states (EQ VAS Score: m = 51, sd = 24, range = 0–90) than the German norm population (m = 77). Around two thirds (68%) of patients reported relevant benefits of therapy (liposuction/lipectomy). In our cohort about one third of the patients reported a positive family history for MSL-like features. Additionally, at least in some patients, a strong genetic factor, compatible with autosomal dominant inheritance, seems a possible major driver of MSL development. Alcohol consumption and MSL development has to be regarded as a controversial issue. Patients suffering from MSL have a clear decrease in quality of life and a marked wish for treatment.

[1]  H. Reichmann,et al.  Neurological multisystem manifestation in multiple symmetric lipomatosis: A clinical and electrophysiological study , 1995, Muscle & nerve.

[2]  A. Hirose,et al.  Benign symmetric lipomatosis associated with alcoholism. , 2006, Internal medicine.

[3]  K. Boycott,et al.  Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy. , 2015, Human molecular genetics.

[4]  J. Li,et al.  The endocrine and metabolic evaluation of benign symmetrical lipomatosis: a case report and literature review. , 2010, Neuro endocrinology letters.

[5]  R. Kessler,et al.  Self-Reported Population Health: An International Perspective based on EQ-5D , 2014, Springer Netherlands.

[6]  O. Braun-falco,et al.  [Benign symmetric Launois-Bensaude type III lipomatosis and Bureau-Barrière syndrome]. , 1991, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[7]  Jun Wang,et al.  [Recent progress on diagnosis and treatment of benign symmetric lipomatosis]. , 2010, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.

[8]  M. Augustin,et al.  Dimensions of patient needs in dermatology: subscales of the patient benefit index , 2010, Archives of Dermatological Research.

[9]  M. Augustin,et al.  Evaluation of patient-relevant outcomes of lymphedema and lipedema treatment: development and validation of a new benefit tool. , 2014, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[10]  G. Enzi Multiple Symmetric Lipomatosis: An Updated Clinical Report , 1984, Medicine.

[12]  J. Granneman,et al.  Adipose tissue plasticity from WAT to BAT and in between. , 2014, Biochimica et biophysica acta.

[13]  G. Sergi,et al.  Multiple symmetric lipomatosis: a rare disease and its possible links to brown adipose tissue. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[14]  J. M. Puebla,et al.  Madelung's disease. , 2013 .

[15]  E. Nisoli,et al.  Multiple symmetric lipomatosis may be the consequence of defective noradrenergic modulation of proliferation and differentiation of brown fat cells , 2002, The Journal of pathology.

[16]  S. Berkovic,et al.  Multiple Symmetrical Lipomatosis--a mitochondrial disorder of brown fat. , 2013, Mitochondrion.

[17]  Y. Bae,et al.  Characterization and Expression Analysis of Mesenchymal Stem Cells from Human Bone Marrow and Adipose Tissue , 2004, Cellular Physiology and Biochemistry.

[18]  M. Correia,et al.  Madelung’s Disease: Revision of 59 Surgical Cases , 2017, Aesthetic Plastic Surgery.

[19]  J. Cameselle-Teijeiro,et al.  Madelung’s Disease: Comorbidities, Fatty Mass Distribution, and Response to Treatment of 22 Patients , 2013, Aesthetic Plastic Surgery.

[20]  Calcyphosine-like (CAPSL) is regulated in Multiple Symmetric Lipomatosis and is involved in Adipogenesis , 2019, Scientific Reports.

[21]  L. Prantl,et al.  Adipose Tissue in Multiple Symmetric Lipomatosis Shows Features of Brown/Beige Fat , 2020, Aesthetic Plastic Surgery.

[22]  G. Enzi,et al.  Multiple symmetric lipomatosis: clinical aspects and outcome in a long-term longitudinal study , 2002, International Journal of Obesity.

[23]  A. Garg,et al.  Homozygous LIPE mutation in siblings with multiple symmetric lipomatosis, partial lipodystrophy, and myopathy , 2017, American journal of medical genetics. Part A.

[24]  W. Greiner,et al.  Validating the EQ-5D with time trade off for the German population , 2005, The European Journal of Health Economics.